15th Jun 2007 15:42
GlaxoSmithKline PLC15 June 2007 GlaxoSmithKline plc received on 14 June 2007 from Legal & General Group Plc anotification of interests in GlaxoSmithKline plc ordinary shares of 25 penceeach dated 13 June 2007. This notice is given in accordance with DTR 5.8.12. TR-1: notification of major interests in shares 1. Identity of the issuer or the underlying issuer of existing GlaxoSmithKline plcshares to which voting rights are attached: 2. Reason for notification (yes/no) An acquisition or disposal of voting rights Yes An acquisition or disposal of financial instruments which may result in the acquisitionof shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify):______________ 3. Full name of person(s) subject to the notification Legal & General Group Plc (L&G)obligation: 4. Full name of shareholder(s) (if different from 3.): Legal & General Assurance (Pensions Management) Limited (PMC) 5. Date of the transaction (and date on which the threshold is 13/06/2007crossed or reached if different): 6. Date on which issuer notified: 14/06/2007 7. Threshold(s) that is/are crossed or reached: From 3% - 4%(L&G) 8. Notified details: A: Voting rights attached to shares Class/type of Situation previous to Resulting situation after the triggering transactionshares the Triggering transaction if possible Number of Number of Number of Number of voting rights % of voting rightsusing the Shares Voting sharesISIN CODE Rights Direct Direct Indirect Direct Indirect Ord GBP 0.25 218,457,607 218,457,607 228,794,061 228,794,061 4.00 B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument Period/ Date that may be acquired if rights the instrument is exercised/ converted. Total (A+B) Number of voting rights % of voting rights 228,794,061 4.00 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable: Legal & General Group Plc (Direct and Indirect) (Group) Legal & General Investment Management (Holdings) Limited (LGIMH) (Directand Indirect) Legal & General Investment Management Limited (Indirect) (LGIM) Legal & General Group Plc (Direct) (L&G) (228,794,061 - 4.00% = LGAS, LGPL & PMC) Legal & General Investment Management (Holdings) Limited Legal & General Insurance Holdings Limited (Direct)(Direct) (LGIMHD) (177,976,339 - 3.11%= PMC) (LGIH) Legal & General Assurance (Pensions Management) Limited (PMC) Legal & General Assurance Society Limited (LGAS & LGPL) (177,976,339 - 3.11%= PMC) Legal & General Pensions Limited (Direct) (LGPL) Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: Notification using the total voting rights figure of 5,706,694,635 14. Contact name: N/A 15. Contact telephone number: N/A Annex Notification Of Major Interests In Shares A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities) Legal & General Group Plc (L&G) Contact address (registered office for legal entities) Temple Court, 11 Queen Victoria Street, London, EC4N 4TP Phone number 020 7528 6000 Other useful information (at least legal representative N/Afor legal persons) B: Identity of the notifier, if applicable Full name Simon Bicknell Contact address GlaxoSmithKline Plc 980 Great West Road Brentford TW8 9GS 020 8047 6280 Phone number 020 8047 6280 Other useful information (e.g. functional relationship Company Secretarywith the person or legal entity subject to thenotification obligation) C: Additional information N/A Notes 1. This form is to be sent to the issuer or underlying issuer and to befiled with the competent authority. 2. Either the full name of the legal entity or another method foridentifying the issuer or underlying issuer, provided it is reliable andaccurate. 3. This should be the full name of (a) the shareholder; (b) the personacquiring, disposing of or exercising voting rights in the cases provided for inDTR5.2.1 (b) to (h); (c) all the parties to the agreement referred to inDTR5.2.1 (a), or (d) the direct or indirect holder of financial instrumentsentitled to acquire shares already issued to which voting rights are attached,as appropriate. In relation to the transactions referred to in points DTR5.2.1 (b) to (h), thefollowing list is provided as indication of the persons who should be mentioned: - in the circumstances foreseen in DTR5.2.1 (b), the person thatacquires the voting rights and is entitled to exercise them under the agreementand the natural person or legal entity who is transferring temporarily forconsideration the voting rights; - in the circumstances foreseen in DTR 5.2.1 (c), the personholding the collateral, provided the collateral under these conditions; - in the circumstances foreseen in DTR5.2.1(d), the person who hasa life interest in shares if that person is entitled to exercise the votingrights attached to the shares and the person who is disposing of the votingrights when the life interest is created; - in the circumstances foreseen in DTR5.2.1 (e), the parentundertaking and, provided it has a notification duty at an individual levelunder DTR 5.1, under DTR5.2.1 (a) to (d) or under a combination of any of thosesituations, the controlled undertaking; - in the circumstances foreseen in DTR5.2.1 (f), the deposit takerof the shares, if he can exercise the voting rights attached to the sharesdeposited with him at his discretion, and the depositor of the shares allowingthe deposit taker to exercise the voting rights at his discretion; - in the circumstances foreseen in DTR5.2.1 (g), the person thatcontrols the voting rights; - in the circumstances foreseen in DTR5.2.1 (h), the proxy holder,if he can exercise the voting rights at his discretion, and the shareholder whohas given his proxy to the proxy holder allowing the latter to exercise thevoting rights at his discretion. 4. Applicable in the cases provided for in DTR 5.2.1 (b) to (h).This should be the full name of the shareholder or holder of financialinstruments who is the counterparty to the natural person or legal entityreferred to in DTR5.2. 5. The date of the transaction should normally be, in the case of anon exchange transaction, the date on which the matching of orders occurs; in thecase of an off exchange transaction, date of the entering into an agreement. The date on which threshold is crossed should normally be the date on which theacquisition, disposal or possibility to exercise voting rights takes effect (seeDTR 5.1.1R (3)). For passive crossings, the date when the corporate event tookeffect.(DEL: :DEL) These dates will usually be the same unless the transaction is subject to acondition beyond the control of the parties. 6. Please refer to the situation disclosed in the previousnotification, In case the situation previous to the triggering transaction wasbelow 3%, please state 'below 3%'. 7. If the holding has fallen below the minimum threshold ,the notifying party should not be obliged to disclose the extent of the holding,only that the new holding is less than 3%. For the case provided for in DTR5.2.1(a), there should be no disclosure ofindividual holdings per party to the agreement unless a party individuallycrosses or reaches an Article 9 threshold. This applies upon entering into,introducing changes to or terminating an agreement. 8. Direct and indirect 9. In case of combined holdings of shares with voting rightsattached 'direct holding' and voting rights 'indirect holdings', please splitthe voting rights number and percentage into the direct and indirect columns-ifthere is no combined holdings, please leave the relevant box blank. 10. Voting rights attached to shares in respect of which thenotifying party is a direct shareholder (DTR 5.1) 11. Voting rights held by the notifying party as an indirectshareholder (DTR 5.2.1) 12. If the holding has fallen below the minimum threshold, thenotifying party should not be obliged to disclose the extent of the holding,only that the new holding is below 3%. 13. date of maturity / expiration of the finical instrument i.e. thedate when the right to acquire shares ends. 14. If the financial instrument has such a period-pleasespecify the period- for example once every three months starting from the (date) 15. The notification should include the name(s) of thecontrolled undertakings through which the voting rights are held. Thenotification should also include the amount of voting rights and the percentageheld by each controlled undertaking, insofar as individually the controlledundertaking holds 3% or more, and insofar as the notification by the parentundertaking is intended to cover the notification obligations of the controlledundertaking. 16. This annex is only to be filed with the competentauthority. 17. Whenever another person makes the notification on behalfof the shareholder or the natural person/legal entity referred to in DTR5.2 andDTR5.3. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
GlaxosmithklineLegal & General